Comparing Inotuzumab Combined With Low Intensity Chemotherapy Plus Blinatumomab to Usual Chemotherapy Plus Blinatumomab in Older Adults With CD22+ B-cell Acute Lymphoblastic Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Marlise R. Luskin, MD, MSCE
Dana-Farber Cancer Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
72 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- San Juan City Hospital
San Juan, Puerto Rico
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Uci Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Irvine, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
- Yale University
New Haven, Connecticut, United States
- Emory University Hospital/winship Cancer Institute
Atlanta, Georgia, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- Saint Luke'S Cancer Institute - Boise
Boise, Idaho, United States
- Saint Alphonsus Cancer Care Center-Caldwell
Caldwell, Idaho, United States
- Kootenai Health - Coeur D'Alene
Coeur d'Alene, Idaho, United States
- Saint Alphonsus Cancer Care Center-Nampa
Nampa, Idaho, United States
- Kootenai Clinic Cancer Services - Post Falls
Post Falls, Idaho, United States
- Kootenai Clinic Cancer Services - Sandpoint
Sandpoint, Idaho, United States
- Northwestern University
Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Northshore University Healthsystem-Evanston Hospital
Evanston, Illinois, United States
- Northshore University Healthsystem-Glenbrook Hospital
Glenview, Illinois, United States
- Northshore University Healthsystem-Highland Park Hospital
Highland Park, Illinois, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- Uc Comprehensive Cancer Center at Silver Cross
New Lenox, Illinois, United States
- University of Chicago Medicine-Orland Park
Orland Park, Illinois, United States
- Memorial Hospital East
Shiloh, Illinois, United States
- Northwestern Medicine Cancer Center Warrenville
Warrenville, Illinois, United States
- University of Kansas Cancer Center
Kansas City, Kansas, United States
- University of Kansas Hospital-Westwood Cancer Center
Westwood, Kansas, United States
- Norton Suburban Hospital and Medical Campus
Louisville, Kentucky, United States
- University of Maryland/greenebaum Cancer Center
Baltimore, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Baptist Memorial Hospital and Cancer Center-Desoto
Southhaven, Mississippi, United States
- Siteman Cancer Center at Saint Peters Hospital
City of Saint Peters, Missouri, United States
- Siteman Cancer Center at West County Hospital
Creve Coeur, Missouri, United States
- Siteman Cancer Center at Christian Hospital
St Louis, Missouri, United States
- Siteman Cancer Center-South County
St Louis, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Community Hospital of Anaconda
Anaconda, Montana, United States
- Billings Clinic Cancer Center
Billings, Montana, United States
- Bozeman Health Deaconess Hospital
Bozeman, Montana, United States
- Benefis Sletten Cancer Institute
Great Falls, Montana, United States
- Logan Health Medical Center
Kalispell, Montana, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Jun 2023
- Primary completion
- 1 Apr 2027
- Completion
- 31 May 2029
- Last update posted
- 10 Jul 2026
- Registered enrollment
- 68
- Registry id
- NCT05303792
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.